American Heart Association

  80
  0


Final ID: Sa2051

A Large Animal Model of Persistent Atrial Fibrillation

Abstract Body (Do not enter title and authors here): Purpose:
Persistent atrial fibrillation (AFib), the most common sustained cardiac arrhythmia in the United States, poses substantial health hazards, such as the formation of blood clots, stroke, and heart failure. Despite available therapies such as ablation and antiarrhythmic drugs, there still is no definitive cure for AFib. Our study aims to bridge this gap by investigating the genetic and molecular factors underlying AFib through the development of an AFib model using Yucatan mini swine as the medium that closely mimics human cardiac physiology.
Methods:
We selected Yucátan mini swine as animal models because they closely resemble humans physiologically and are of a convenient size for performing extended experiments. We surgically implanted pacing leads, implantable cardiac monitors (ICMs), and pacing generators into the swine, along with external Fitbark 2.0 Collars to use activity levels as a measurement of quality of life. After the procedures the swine underwent rapid atrial pacing with the intention to induce persistent atrial fibrillation.
Findings:
An electrocardiogram (ECG) showed that the method of stimulating the right atrium of the heart induced persistent atrial fibrillation in pigs and decreased levels of activity, indicating a decline in their general health. This continued for >7 days after atrial pacing was terminated. Overcoming challenges associated with animal dimensions and model design, we devised specific surgical techniques, including jugular cut-down, lateral cervical implantation coupled with antibiotic support, long sheaths, and customized styluses. These innovations were instrumental in achieving a successful AFib model and overcoming anatomical obstacles.
Summary:
Our study demonstrates the feasibility of creating a large animal model of AFib using Yucatan mini swine. This model closely resembles the clinical presentation of human AFib and could provide valuable insights into the disease mechanism and potential therapeutic strategies. Animal heart and vascular dimensions were the most challenging surgically.
  • Mostafizi, Pouria  ( Sarver Heart Center- UACOM-Tucson , Tucson , Arizona , United States )
  • Goldman, Steven  ( Sarver Heart Center- UACOM-Tucson , Tucson , Arizona , United States )
  • Moukabary, Talal  ( University of Arizona , Tucson , Arizona , United States )
  • Lefkowitz, Eli  ( University of Arizona , Tucson , Arizona , United States )
  • Ref, Jacob  ( Sarver Heart Center- UACOM-Tucson , Tucson , Arizona , United States )
  • Daugherty, Sherry  ( Sarver Heart Center- UACOM-Tucson , Tucson , Arizona , United States )
  • Grijalva, Adrian  ( Sarver Heart Center- UACOM-Tucson , Tucson , Arizona , United States )
  • Cook, Kyle Eric  ( Sarver Heart Center- UACOM-Tucson , Tucson , Arizona , United States )
  • Chinyere, Ike  ( University of Arizona , Tucson , Arizona , United States )
  • Lancaster, Jordan  ( Sarver Heart Center- UACOM-Tucson , Tucson , Arizona , United States )
  • Koevary, Jen  ( University of Arizona , Tucson , Arizona , United States )
  • Author Disclosures:
    Pouria Mostafizi: DO NOT have relevant financial relationships | Steven Goldman: DO have relevant financial relationships ; Individual Stocks/Stock Options:Avery Therapeutics/ Sarver Heart Center:Active (exists now) ; Researcher:Sarver Heart Center, University of Arizona:Active (exists now) | Talal Moukabary: DO NOT have relevant financial relationships | Eli Lefkowitz: DO NOT have relevant financial relationships | Jacob Ref: No Answer | Sherry Daugherty: No Answer | Adrian Grijalva: DO NOT have relevant financial relationships | Kyle Eric Cook: DO NOT have relevant financial relationships | Ike Chinyere: DO NOT have relevant financial relationships | Jordan Lancaster: DO NOT have relevant financial relationships | Jen Koevary: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Learning & Burning: Insights into Ventricular Arrhythmia Management

Saturday, 11/16/2024 , 10:30AM - 11:30AM

Abstract Poster Session

More abstracts on this topic:
A RETROSPECTIVE EVALUATION OF RESOURCE UTILIZATION AND OUTCOMES IN PATIENTS USING MOBILE ECG DEVICES FOLLOWING ABLATION FOR ATRIAL FIBRILLATION

Fairman Alix, Loh Alexander, Druml Lauren, Triplett Cynthia, Liu Taylor, Pursnani Seema

A Comparative Analysis of Esophageal Cooling for Preventing Esophageal Injury Post Atrial Fibrillation Catheter Ablation: A Systematic Review and Meta-analysis

Ibrahim Momen Mohamed, Al Hennawi Hussam, Tanas Yousef, Abourady Youmna, Sewedan Nourhan, Hashem Ahmed Magdy, Motawea Karam R.

More abstracts from these authors:
Defining Predictive Signatures for Diagnostic, Prognostic, and Therapeutic Indices for Tissue Repair in Chronic Ischemic Heart Failure

Benson Daniel, Mangiola Massimo, Pandey Amitabh, Arunachalam Prabhu, Fain Mindy, Nikolich Janko, Koevary Jen, Lancaster Jordan, Goldman Steven, Singh Simar, Grijalva Adrian, Fink Jordan, Tulino Allison, Deeb Michael, O'donnell Deirdre, Coletta Dawn, Langlais Paul

Tissue Engineered Biologic Promotes Cardiac Repair in Animal Models of Chronic Ischemic Heart Failure via Immunomodulation

Tulino Allison, Benson Daniel, Grijalva Adrian, Fink Jordan, Ref Jacob, Koevary Jen, Goldman Steven, Lancaster Jordan

You have to be authorized to contact abstract author. Please, Login
Not Available